Literature DB >> 32801046

Update on IgG4-mediated autoimmune diseases: New insights and new family members.

Inga Koneczny1.   

Abstract

Antibodies of IgG4 subclass are exceptional players of the immune system, as they are considered to be immunologically inert and functionally monovalent, and as such may be part of classical tolerance mechanisms. IgG4 antibodies are found in a range of different diseases, including IgG4-related diseases, allergy, cancer, rheumatoid arthritis, helminth infection and IgG4 autoimmune diseases, where they may be pathogenic or protective. IgG4 autoimmune diseases are an emerging new group of diseases that are characterized by pathogenic, antigen-specific autoantibodies of IgG4 subclass, such as MuSK myasthenia gravis, pemphigus vulgaris and thrombotic thrombocytopenic purpura. The list of IgG4 autoantigens is rapidly growing and to date contains 29 candidate antigens. Interestingly, IgG4 autoimmune diseases are restricted to four distinct organs: 1) the central and peripheral nervous system, 2) the kidney, 3) the skin and mucous membranes and 4) the vascular system and soluble antigens in the blood circulation. The pathogenicity of IgG4 can be validated using our classification system, and is usually excerted by functional blocking of protein-protein interaction.
Copyright © 2020 The Author. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoantibodies; Autoimmunity; Classification; IgG4; Pathogenic mechanisms

Mesh:

Substances:

Year:  2020        PMID: 32801046     DOI: 10.1016/j.autrev.2020.102646

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  13 in total

1.  A systematic review and meta-analysis of HLA class II associations in patients with IgG4 autoimmunity.

Authors:  Anja Panhuber; Giovanni Lamorte; Veronica Bruno; Hakan Cetin; Wolfgang Bauer; Romana Höftberger; Astrid C Erber; Florian Frommlet; Inga Koneczny
Journal:  Sci Rep       Date:  2022-06-02       Impact factor: 4.996

Review 2.  Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?

Authors:  Inga Koneczny; Vuslat Yilmaz; Konstantinos Lazaridis; John Tzartos; Tobias L Lenz; Socrates Tzartos; Erdem Tüzün; Frank Leypoldt
Journal:  Front Immunol       Date:  2021-01-29       Impact factor: 7.561

3.  Functional monovalency amplifies the pathogenicity of anti-MuSK IgG4 in myasthenia gravis.

Authors:  Dana L E Vergoossen; Jaap J Plomp; Christoph Gstöttner; Yvonne E Fillié-Grijpma; Roy Augustinus; Robyn Verpalen; Manfred Wuhrer; Paul W H I Parren; Elena Dominguez-Vega; Silvère M van der Maarel; Jan J Verschuuren; Maartje G Huijbers
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-30       Impact factor: 11.205

Review 4.  Pathophysiology of the Different Clinical Phenotypes of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP).

Authors:  Edyta Dziadkowiak; Marta Waliszewska-Prosół; Marta Nowakowska-Kotas; Sławomir Budrewicz; Zofia Koszewicz; Magdalena Koszewicz
Journal:  Int J Mol Sci       Date:  2021-12-24       Impact factor: 5.923

5.  Anti-Neuronal IgG4 Autoimmune Diseases and IgG4-Related Diseases May Not Be Part of the Same Spectrum: A Comparative Study.

Authors:  Verena Endmayr; Cansu Tunc; Lara Ergin; Anna De Rosa; Rosa Weng; Lukas Wagner; Thin-Yau Yu; Andreas Fichtenbaum; Thomas Perkmann; Helmuth Haslacher; Nicolas Kozakowski; Carmen Schwaiger; Gerda Ricken; Simon Hametner; Sigrid Klotz; Lívia Almeida Dutra; Christian Lechner; Désirée de Simoni; Kai-Nicolas Poppert; Georg Johannes Müller; Susanne Pirker; Walter Pirker; Aleksandra Angelovski; Matus Valach; Michelangelo Maestri; Melania Guida; Roberta Ricciardi; Florian Frommlet; Daniela Sieghart; Miklos Pinter; Karl Kircher; Gottfried Artacker; Romana Höftberger; Inga Koneczny
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

Review 6.  IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies.

Authors:  Inga Koneczny; John Tzartos; Marina Mané-Damas; Vuslat Yilmaz; Maartje G Huijbers; Konstantinos Lazaridis; Romana Höftberger; Erdem Tüzün; Pilar Martinez-Martinez; Socrates Tzartos; Frank Leypoldt
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

7.  Altered abundances of human immunoglobulin M and immunoglobulin G subclasses in Alzheimer's disease frontal cortex.

Authors:  Rukmani Lekhraj; Shirin Lalezari; Jennifer T Aguilan; Jiyue Qin; Simone Sidoli; Wenzhu Mowrey; Seema Gollamudi; Parviz Lalezari
Journal:  Sci Rep       Date:  2022-04-28       Impact factor: 4.996

Review 8.  Short- and Long-Lived Autoantibody-Secreting Cells in Autoimmune Neurological Disorders.

Authors:  C Zografou; A G Vakrakou; P Stathopoulos
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

Review 9.  B cells and the microbiota: a missing connection in food allergy.

Authors:  Evelyn Campbell; Lauren A Hesser; Cathryn R Nagler
Journal:  Mucosal Immunol       Date:  2020-10-26       Impact factor: 8.701

Review 10.  IgG4 as a Biomarker in Graves' Orbitopathy.

Authors:  Michał Olejarz; Ewelina Szczepanek-Parulska; Daniela Dadej; Nadia Sawicka-Gutaj; Remigiusz Domin; Marek Ruchała
Journal:  Mediators Inflamm       Date:  2021-06-10       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.